Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

A strong quarter concludes a successful year

Fourth quarter · Organic sales rose 17.9 per cent in the quarter compared to the previous year. Acquisition effects amounted to 8.9  per cent and currency effects were 9.3 per cent. Net sales increased by 36.2 per cent and amounted to SEK 5,818 million (4,271). · EBITA before items affecting comparability amounted to SEK 570 million (338), which is an increase of 69 per cent compared to the same period the previous year. The EBITA margin amounted to 9.8 per cent (7.9). · This is Beijer Ref’s best fourth quarter ever, excluding items affecting comparability, both in absolute terms

Pihlajalinna’s Shareholders’ Nomination Board continues to prepare the Proposals for the 2023 Annual General Meeting

Pihlajalinna Plc         Stock Exchange Release         31 January 2023 at 9:30 a.m. Pihlajalinna’s Shareholders’ Nomination Board continues to prepare the Proposals for the 2023 Annual General Meeting The Pihlajalinna Plc’s Shareholders’ Nomination Board continues to prepare in good cooperation the Proposals for the composition and remuneration of the Board of Directors for the 2023 Annual General Meeting. The goal is to have the Proposals completed by the time the Notice of Annual General Meeting will be published. The Pihlajalinna Shareholders’ Nomination Board consists of the

Inhalation Sciences receives IRS order worth over 914,000 SEK from new US pharma customer

Inhalation Sciences AB (ISAB) has received an order worth over 914,000 SEK (81,200 Euros) for an Inhalation Research Service (IRS) project from a new US customer developing targeted antiviral therapies. In this first project they have chosen to use the DissolvIt[®] module to carry out dissolution testing, due to its exceptional accuracy which can reduce risk and attrition in later drug development.ISAB has received an order from a new customer, a cutting-edge US pharmaceutical company developing novel antiviral therapies to treat a range of viral diseases from influenza to COVID-19.

Cereno Scientific to present CS585’s preclinical data at scientific congress ACC.23/WC

Cereno Scientific (XSAT: CRNO B) today announced that an abstract on preclinical drug candidate CS585 has been accepted as a moderated poster presentation at the ACC.23/WCC hosted by the American College of Cardiology Together With WCC (World Congress of Cardiology), in New Orleans, US, on March 4-6, 2023. The abstract titled “CS585 is a novel orally available prostacyclin receptor agonist with long-term in vivo inhibition of platelets and thrombosis formation in mouse without increased risk of bleeding” will be presented by Dr. Michael Holinstat, lead of Cereno’s development programs at

United Bankers Plc’s shareholders’ proposals to the Annual General Meeting 2023

United Bankers Plc STOCK EXCHANGE RELEASE 31 January 2023 at 9:30 EET     United Bankers Plc’s shareholders’ proposals to the Annual General Meeting 2023 United Bankers Plc’s shareholders who represent approximately 40 per cent of all shares and votes in the Company (31 December 2022) have submitted a proposal to the Annual General Meeting to be held on 22 March 2023 concerning the composition of the Board of Directors and the remuneration of the members of the Board of Directors.   Number and election of the Board members The shareholders propose that the number of

Invitation to the presentation of Ratos Year-end report 2022

The Year-end report 2022 will be released on Monday 13 February at 07.00 CET.At 09.00 CET will Jonas Wiström, President and CEO, and Jonas Ågrup, CFO, present the report.The presentation can be followed on Youtube via the following link; https://youtu.be/6rBHv2vp6t4. The live presentation will be recorded and is available afterwards via the same link.Participants who wish to ask questions live are asked to pre-register, please send an e-mail to helena.jansson@ratos.com in advance for a personal invitation.The presentation and report will be available on www.ratos.com after publication.

Katalysen Ventures completes a directed share issue of 805’000 new shares, raising proceeds of approximately SEK 11.9 million from strategic investors

The board of directors of Katalysen Ventures AB (publ) (”Katalysen” or the ”Company”) has today resolved to carry out a directed share issue of 805’000 new shares at a subscription price of SEK 14.75 per share corresponding to a discount of approximately 7.8% compared to the closing price of SEK 16.00 on 27 January 2023. Through the directed share issue, Katalysen will receive proceeds amounting to approximately SEK 11.9 million before transaction costs. Total transaction costs are estimated at SEK 10’000.The board of directors of Katalysen has today, based on the authorization granted by

Betolar Plc’s Shareholders’ Nomination Committee’s Proposals to the General Meeting 2023

Betolar Plc Company Release  31 January 2023 at 9:15 AM EEST Betolar Plc’s Shareholders’ Nomination Committee’s Proposals to the General Meeting 2023 Betolar Plc’s (“Betolar”) Annual General Meeting is planned to be held on Friday 31 March 2023. Betolar’s Shareholders’ Nomination Committee has resolved to make the following proposals to the Annual General Meeting: Number of members of the Board of Directors The Shareholders’ Nomination Committee proposes to the Annual General Meeting that the number of the members of the Board of Directors would be six (6) (6 members in

Nilar doubles production rate

Last fall, Nilar International AB began production of the next generation battery system, the only one in the world that can be refilled with new life. At the end of February, the production rate will increase further to four production lines – close to doubling today's volume.- At our factory in Gävle, we develop and produce one of the world's most durable and safe batteries. The doubling of the production rate also means that we are fully in line with our long-term goals and plan for volume growth, says Erik Oldmark, CEO of Nilar International AB. Together with selected partners, Nilar

Össur hf: Annual Report 2022

Announcement no. 03/2023 Annual Report 2022 31 January 2023 Annual Report 2022 Össur’s Annual Report 2022 has just been published and is available for download at the link below. An online version of the Annual Report 2022 is available at https://annual-report.ossur.com/ Further information Edda Lára Lúðvígsdóttir, Investor Relations Director, eludvigsdottir@ossur.com, +354 844 4759 Össur press releases by e-mail If you wish to receive Össur press releases by e-mail, please register at http://www.ossur.com/investors About Össur Össur (Nasdaq Copenhagen: OSSR)

AFRY to design part of Ostkustbanan in Sweden

The Swedish Transport Administration, Trafikverket, is planning to increase the capacity on Ostkustbanan by building double tracks between Dingersjö and Sundsvall. Dingersjö – Kubikenborg is a 10-kilometer-long section of this double track extension. AFRY is commissioned to design and develop a railway plan for the route.Ostkustbanan is a 400-kilometer-long railway between Sundsvall and Stockholm and one of Sweden’s busiest railway sections. The conversion to double track allows for increased passenger and freight traffic as well as provides shorter journey times. The reconstruction is a

Ahlstrom’s FluoroFree® Technology leads the industry in next generation grease-resistant packaging solutions

AHLSTROM OYJ PRESS RELEASE JANUARY 31 at 9:00 AM EET  Ahlstrom has led the marketplace in the movement towards more sustainable solutions for fiber-based food packaging, and its new generation of FluoroFree® technology is achieving grease-resistance in the most challenging food packaging applications. “We have been on a continuous development journey of our proprietary FluoroFree® family of grease-resistant products for more than a decade, and we continue to push the boundaries on grease-resistance capabilities,” explained Travis Dahlke, Vice President of Ahlstrom’s North American

Conversion of shares

According to Essity’s articles of association, owners of Class A shares have the right to have such shares converted to Class B shares. Conversion reduces the total number of votes in the company. When such a conversion has occurred, the company is obligated by law to disclose any such changes in this manner.In January, at the request of shareholders, 50,000 Class A shares were converted to Class B shares. The total number of votes in the company thereafter amounts to 1,252,772,715. The total number of registered shares in the company amounts to 702,342,489 of which 61,158,914 are Class

Energy efficiency in focus: targeting energy savings of 46% for two schools in Helsinki

Caverion Corporation Article 31 January 2023 at 9.00 a.m. EETEnergy efficiency in focus: targeting energy savings of 46% for two schools in Helsinki The City of Helsinki and Caverion will improve energy-efficiency in three city properties. The goal is to save energy equivalent to the annual consumption of 85 average private homes. The City of Helsinki aims to be carbon neutral by 2030. The city and Caverion have now started ESCO projects to improve energy-efficiency in two schools and in a kindergarten. “Service buildings like schools and kindergartens are significant energy consumers

Autoliv Retires Treasury Shares, Decreases Number of Issued Shares

(Stockholm, Sweden, January 31, 2023) - Autoliv, Inc. (NYSE: ALV and SSE: ALIVsdb), the worldwide leader in automotive safety systems, today announced that as of January 31, 2023, the total number of outstanding shares of common stock is 86,187,746 and the number of issued and outstanding shares of common stock  is 91,167,783.Autoliv retired 10,000,000 shares of common stock that had been held in treasury by the Company, which resulted in a decrease in the issued shares. The retirement of the treasury shares and resulting decrease in the number of issued shares of common stock had no

Electrolux Professional AB year-end report Q4 2022

Fourth quarter, October–December 2022· Net sales amounted to SEK 3,040m (2,309). Sales increased by 31.7%. Organically sales increased by 13.4%. The acquisition of Unified Brands contributed with 10.3%. Currency had a positive effect of 9.6%, and the divestment of the Russian business had an effect of –1.7%. · EBITA amounted to SEK 324m (164), corresponding to a margin of 10.7% (7.1). · Operating income amounted to SEK 284m (141), corresponding to a margin of 9.3% (6.1). · Operating cash flow after investments amounted to SEK 533m (459). · Income for the period amounted to SEK

Aker Carbon Capture enters Finnish Power-to-X market

Aker Carbon Capture will deliver a pre-engineering study to the energy company St1 for the development of a carbon capture facility at Finnsementti’s Lappeenranta cement plant. The captured CO2 would be used for the first renewable synthetic methanol plant in Finland. Aker Carbon Capture’s Just Catch unit could capture around 40,000 tonnes CO2 per year, enabling the production of 25,000 tonnes of methanol per year.Aker Carbon Capture is currently delivering the world’s first carbon capture facility at Norcem’s cement plant in Brevik, Norway, and will bring learnings from this project into

Number of shares and votes in Calliditas Therapeutics

During January, Calliditas Therapeutics AB (publ) has issued 7,500 common shares connected to the company’s long term incentive program 2019/2022. Thus, as of January 31, 2023, the number of shares and votes in the company amounts to 59,580,087 shares and 59,580,087 votes. For further information, please contact: Mikael Widell, Investor relations Tel.: +46 703 11 99 60, email: mikael.widell@calliditas.com The information in the press release is such that Calliditas Therapeutics AB (publ) is required to disclose pursuant to the Swedish Financial Instruments Trading Act. The

Total Voting Rights

("Amaroq" or the "Company") Total Voting Rights TORONTO, ONTARIO - 31 January, 2023 - Amaroq Minerals Ltd. (AIM, TSXV, NASDAQ First North: AMRQ), an independent mine development company with a substantial land package of gold and strategic mineral assets covering an area of 7,866.85 km[2] in Southern Greenland, announces, in accordance with the FCA's Disclosure Guidance and Transparency Rule 5.6.1, that as at 31 January 2023, its share capital consists of 263,211,732 common shares of no par value each, and each with voting rights. Given the Company does not hold any common shares in

Year-End Report Byggmax Group January 1 - December 31, 2022

Stronger position in a tough marketSummary of the fourth quarter of 2022• Net sales amounted to SEK 1,170 M (1,301), representing a decrease of 10.0 percent.• The Group’s currency adjusted like-for-like sales decreased by 15.2 percent.• The gross margin was 35.2 percent (34.8).• EBITA amounted to SEK -28 M (25), with an EBITA margin of -2.4 percent (1.9).• EBIT amounted to SEK -42 M (12), with an EBIT margin of -3.6 percent (0.9).• Net profit for the period amounted to SEK -60 M (-22).• Earnings per share totaled SEK 1.03 (-0.37).• Cash flow from operating activities amounts

Nordnet publishes its Year-end report

Nordnet AB (publ) today publishes its Year-end report 2022. The full report is available at www.nordnetab.com.“Despite challenging environmental factors, our fourth quarter financial results are very strong. Nordnet’s operations are well diversified from both a geographic and product perspective, ensuring high revenue and good profitability in a variety of macroeconomic environments. Revenue from equity trading and mutual fund savings in the fourth quarter decreases compared to the same period last year but are more than compensated for by a higher net interest income. Total revenue for the

Invitation to presentation of Q4 2022 financial results

Viaplay Group will publish its Q4 2022 financial results at 07:30 CET on Tuesday 14 February. A video webcast and conference call will be hosted at 09:00 CET on Tuesday 14 February by Matthew Hooper, Acting Head of Investor Relations, with presentations from Anders Jensen, President and CEO, and Enrique Patrickson, Chief Financial Officer. A question-and-answer session will follow the presentations.   Video webcastThe video webcast will be streamed on the following link, where questions can also be posted: https://edge.media-server.com/mmc/p/9mvjcf8e Conference callPlease

Össur hf: Interim Report Q4 & FY 2022

Announcement no. 02/2023 Interim report Q4 & FY 2022 31 January 2023 Sveinn Sölvason, President and CEO, Comments: “Sales amounted to 191 million and the EBITDA margin before special items was 18% in Q4 2022. Despite a challenging external environment, we have grown the business in all regions and business segments in 2022. We ended the year with a strong quarter of growth driven by prosthetics sales in Americas and EMEA, and bionic sales were particularly strong. As we remain focused on growth and innovation, we successfully launched our Power Knee, the first motor powered

Genetic Analysis strengthens and future-proofs the organization

OSLO, NORWAY, January 31, 2023 – Molecular diagnostics specialist, Genetic Analysis AS (“GA”) is happy to announce that GA is strengthening and future-proofing the organization within business development, sales, and product development to be better positioned to harvest opportunities in the microbiome market. As diagnostics is now becoming a vital part of the treatment regime for gastroenterological disorders, GA believes that the microbiome diagnostic market will continue to rapidly increase in the coming years.  Following the recent regulatory approval of microbiome-altering drugs in the

There are no items matching the current filter
There are no more items matching the current filter
Back to top